$10.77
0%
Price vs. AI Score (Last 150 days)
Data gathered: November 30
Data gathered: November 30
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 15 0% |
|
| Sentiment | 80 -5.9% |
|
| Webpage traffic | 25,000 24.3% |
|
| Employee Rating | 71 0% |
|
| Google Adspend | $ N/A | N/A |
| Google Trends | 31 -11.4% |
|
| Linkedin Employees | 275 N/A |
|
| Patents | 84 0% |
|
| 4chan Mentions | 0% |
|
| Stocktwits Mentions | 4 0% |
|
| Stocktwits Subscribers | 16,913 -0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| ESG | 43 -2.3% |
|
| Business outlook | 57 0% |
|
In the news
 |
Editas Medicine, Inc. (EDIT) 6th Annual Evercore ISI HealthCONx Conference (Transcript)November 27 - SeekingAlpha |
 |
Editas Medicine, Inc. (NASDAQ:EDIT) is a favorite amongst institutional investors who own 69%November 26 - Yahoo |
 |
CRISPR-Cas9 Gene Editing Is On The Cusp Of Something BigNovember 24 - SeekingAlpha |
Hidden Gems for Hefty Returns: 3 Stocks Set to Double Your Wealth Next YearNovember 21 - InvestorPlace |
|
Market Today: Tech Giants and Biotech Suffer Amid Market RetreatNovember 20 - GuruFocus |
|
Gene editing stocks slide after two-day rallyNovember 20 - Seeking Alpha |
|
About Editas Medicine
Editas Medicine is a clinical-stage biotechnology company which is developing therapies based on CRISPR–Cas9 gene editing technology. Editas is based in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
| Price | $10.77 |
| Target Price | Sign up |
| Market Cap | $864M |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 5.3M | 15M | -9.7M | -45M | -45M |
| Q2 '23 | 2.9M | 17M | -14M | -40M | -44M |
| Q1 '23 | 8.3M | 23M | -15M | -49M | -51M |
| Q4 '22 | 6.5M | 18M | -11M | -61M | -63M |
| Q3 '22 | 42,000 | 16M | -16M | -56M | -56M |
Insider Transactions
| Eaton Bruce filed to sell 74,894 shares at $8.2. November 16 '23 |
| Eaton Bruce filed to sell 75,589 shares at $8.4. November 9 '23 |
| Eaton Bruce filed to sell 75,728 shares at $8.8. September 7 '23 |
| Eaton Bruce filed to sell 75,831 shares at $8.6. August 15 '23 |
| Eaton Bruce filed to sell 76,533 shares at $8.4. August 10 '23 |
Read more about Editas Medicine and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, stocktwits mentions, stocktwits subscribers, news mentions, reddit mentions, esg, business outlook.